Trial
NCT03956056
Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Washington University School of Medicine
Collaborators
National Institutes of Health (NIH); National Cancer Institute (NCI)
Condition
Pancreas Cancer
Intervention
Neoantigen Peptide Vaccine
Why stopped
Insufficient funding/staff
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-07-17